Inovio Pharmaceuticals Inc. (INO) is a clinical-stage biotechnology company whose shares are currently trading at $1.13, following a recent 35.06% downside price move. This analysis outlines key technical levels, prevailing market context, and potential near-term scenarios for INO, with no investment recommendations included. Notably, no recent earnings data is available for the company at the time of writing, so near-term price action is expected to be driven by technical dynamics, sector senti
INO Stock Analysis: Inovio Pharmaceuticals Inc. plunges 35% to $1.13 biotech support level
INO - Stock Analysis
4450 Comments
1361 Likes
1
Basile
Regular Reader
2 hours ago
{协议答案}
👍 138
Reply
2
Norrin
Daily Reader
5 hours ago
{协议答案}
👍 81
Reply
3
Iliam
Community Member
1 day ago
{协议答案}
👍 219
Reply
4
Lyxander
Loyal User
1 day ago
{协议答案}
👍 88
Reply
5
Eural
Elite Member
2 days ago
{协议答案}
👍 48
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.